Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (11-20 of 395) with videos related to

Pageof 40
Sort By:
Brain : a Journal of Neurology|March 4, 2016
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomographySebastian Palmqvist, Niklas Mattsson, Oskar Hansson, et al.
International Journal of Alzheimer'S Disease|August 28, 2010
To know or not to know: ethical issues related to early diagnosis of Alzheimer's diseaseNiklas Mattsson, David Brax, Henrik Zetterberg
Brain : a Journal of Neurology|July 8, 2016
Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson
Lakartidningen|July 6, 2004
[Helicobacter pylori can in rare cases be the cause of iron and vitamin B 12 deficiency. No increased risk of iron and vitamin B 12 deficiency due to proton pump inhibitors]Niklas Mattsson, Anders Kilander, Einar Björnsson
Clinical Chemistry and Laboratory Medicine|March 6, 2010
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fallNiklas Mattsson, Kaj Blennow, Henrik Zetterberg
International Journal of Alzheimer'S Disease|August 20, 2010
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's DiseaseNiklas Mattsson, Henrik Zetterberg, Kaj Blennow
International Journal of Alzheimer'S Disease|April 14, 2011
Cerebrospinal fluid analysis should be considered in patients with cognitive problemsHenrik Zetterberg, Niklas Mattsson, Kaj Blennow
Annals of the New York Academy of Sciences|November 13, 2009
CSF biomarkers: pinpointing Alzheimer pathogenesisNiklas Mattsson, Kaj Blennow, Henrik Zetterberg
Cell Reports. Medicine|September 18, 2024
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's diseaseGabriele Vilkaite, Jacob Vogel, Niklas Mattsson-Carlgren
Alzheimer'S Research & Therapy|December 3, 2010
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer diseaseHenrik Zetterberg, Niklas Mattsson, Kaj Blennow, et al.
Pageof 40

Showing results (11-20 of 395) with videos related to

Sort By:
Pageof 40
Brain : a Journal of Neurology|March 4, 2016
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomographySebastian Palmqvist, Niklas Mattsson, Oskar Hansson, et al.
International Journal of Alzheimer'S Disease|August 28, 2010
To know or not to know: ethical issues related to early diagnosis of Alzheimer's diseaseNiklas Mattsson, David Brax, Henrik Zetterberg
Brain : a Journal of Neurology|July 8, 2016
Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson
Lakartidningen|July 6, 2004
[Helicobacter pylori can in rare cases be the cause of iron and vitamin B 12 deficiency. No increased risk of iron and vitamin B 12 deficiency due to proton pump inhibitors]Niklas Mattsson, Anders Kilander, Einar Björnsson
Clinical Chemistry and Laboratory Medicine|March 6, 2010
Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fallNiklas Mattsson, Kaj Blennow, Henrik Zetterberg
International Journal of Alzheimer'S Disease|August 20, 2010
Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's DiseaseNiklas Mattsson, Henrik Zetterberg, Kaj Blennow
International Journal of Alzheimer'S Disease|April 14, 2011
Cerebrospinal fluid analysis should be considered in patients with cognitive problemsHenrik Zetterberg, Niklas Mattsson, Kaj Blennow
Annals of the New York Academy of Sciences|November 13, 2009
CSF biomarkers: pinpointing Alzheimer pathogenesisNiklas Mattsson, Kaj Blennow, Henrik Zetterberg
Cell Reports. Medicine|September 18, 2024
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's diseaseGabriele Vilkaite, Jacob Vogel, Niklas Mattsson-Carlgren
Alzheimer'S Research & Therapy|December 3, 2010
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer diseaseHenrik Zetterberg, Niklas Mattsson, Kaj Blennow, et al.
Pageof 40